Cronos Group Inc
CRON
Company Profile
- Business description- Cronos Group Inc headquartered in Toronto, Canada, cultivates and sells medicinal and recreational cannabis through its medicinal brand, Peace Naturals, and its two recreational brands, Cove and Spinach. Although it primarily operates in Canada, Cronos exports medical cannabis primarily to Israel. In the U.S., the company has an option to acquire 5.9% of U.S. multistate operator PharmaCann on a fully diluted basis upon easing of federal prohibition. 
- Contact- 111 Peter Street 
 Suite 300
 TorontoONM5V 2H1
 CAN- T: +1 416 504-0004 
- Sector- Healthcare - Stock type- Defensive 
- Industry- Drug Manufacturers - Specialty & Generic - Fiscal Year End- 31 December 2025 - Employees- 459 
Cronos Group Inc News & Analysis
stocks
24 stocks for 2030
Morningstar thinks these companies are well positioned to benefit from one of five key trends during the next decade, writes Susan Dziubinski.
stocks
Waiting for the cannabis hit: 7 stocks for your watchlist
In ten years’ time, you won’t be illegally smoking cannabis, you’ll be legally eating it. Here are some stocks to watch.
stocks
Cannabis: the world in 2030
Morningstar equity analyst Kristoffer Inton on the outlook for the seven producers under coverage.
Morningstar Investment Ideas
Markets
| Index | Last price | Change | % Change | 
|---|---|---|---|
| All Ordinaries | 9,205.00 | 1.70 | -0.02% | 
| CAC 40 | 8,157.29 | 43.59 | -0.53% | 
| DAX 40 | 24,118.89 | 5.32 | -0.02% | 
| Dow JONES (US) | 47,522.12 | 109.88 | -0.23% | 
| FTSE 100 | 9,760.06 | 3.92 | 0.04% | 
| HKSE | 26,050.08 | 232.61 | -0.89% | 
| NASDAQ | 23,581.14 | 377.33 | -1.57% | 
| Nikkei 225 | 52,211.69 | 886.08 | 1.73% | 
| NZX 50 Index | 13,544.51 | 85.22 | 0.63% | 
| S&P 500 | 6,822.34 | 68.25 | -0.99% | 
| S&P/ASX 200 | 8,909.10 | 4.10 | -0.05% | 
| SSE Composite Index | 3,961.62 | 25.28 | -0.63% |